The QualityStocks Daily Thursday, September 13th, 2018

Today's Top 3 StockMarketWatch

StreetInsider (NIO) +75.76%

TopPennyStockMovers (OROXF) +74.86%

QualityStocks (NUZE) +58.33%

The QualityStocks Daily Stock List

Glance Technologies, Inc. (GLNNF)

MarketWatch, InvestorsHub, Evergreen Caller, and Emerging Growth reported on Glance Technologies, Inc. (GLNNF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Glance Technologies, Inc. owns and operates Glance Pay. This is a streamlined payment system. Glance Pay transforms how smartphone users choose where to dine, order food and drink, settle bills, access digital receipts, earn first-rate rewards, and interact with merchants. With the Glance Pay mobile payment app, there is no set up or cancellation fees and no system integration or connections required. Glance Technologies is headquartered in Vancouver, British Columbia.

The Company is building a valuable network of merchants and consumers. Glance Technologies offers targeted in-app marketing, social media marketing, customer feedback, in-merchant messaging, as well as custom rewards programs.

The Glance Pay mobile payment app works for full service restaurants, quick serve restaurants (QSRs), retail, and more. In addition, it features easy activation and training, easy automatic accounting and reconciliation, and speedy payment deposits. Servers and managers can review transaction details.

The Glance Pay mobile payment system comprises proprietary technology. This technology includes user apps available for free downloads in IOS (Apple) and Android formats, a merchant manager apps, a large-scale technology hosting environment with sophisticated anti-fraud technology, and very quick payment processing.

The Company plans to launch a "Glance" token. It will be granted as a reward to users of the Glance Pay mobile payment app every time they make a payment on the Glance Pay mobile network. The reward will apply to all payments, whether the payment is made with the new cryptocurrency or by other payment methods.

In addition, Glance Technologies intends to apply elements of its anti-fraud technology to cryptocurrencies. This is to reduce the risk associated with converting traditional currencies to and from cryptocurrencies.

Glance Technologies previously agreed to license its mobile payment technology to Active Pay Distribution, Inc. for $1,000,000. This marks Glance Technologies’ entry into the fitness and wellness market. Glance Pay will create and provide the technology backbone for the Active Pay app that will serve the emergent fitness and wellness community.

The app will be named Active Pay. It will be innovatively branded as Active Pay. However, it will be labeled as "powered by Glance Pay".

Glance Technologies has entered into a non-binding Letter of Intent (LOI) to acquire Blockimpact from Ztudium Limited. With the LOI, Glance will acquire all of the intellectual property (IP) comprising the BlockImpact platform for US$1.1 million. BlockImpact is a complete end-to-end cryptocurrency blockchain solution. Blockimpact is a blockchain and cryptocurrency with a rewards tokenization platform.

Glance Technologies has been chosen by the National Restaurant Association as one of 14 exhibitors to join its exclusive Startup Alley at the forthcoming National Restaurant Association Show 2018. This is the industry's premier event. It is also the largest foodservice trade show in the United States. This year's show runs from May 19 to 22 in Chicago, Illinois.

In February, Glance Technologies announced it is going after opportunities to license its recently acquired BlockImpact cryptocurrency and blockchain platform as a white label solution. The Company’s belief is that there is high demand in the market for applications of this technology platform. Glance Technologies has had discussions with several parties interested in licensing the technology.

Regarding its Glance Pay app, Glance Technologies has now signed greater than 350 locations for use of the Glance Pay app. This includes more than a dozen U.S. locations ahead of the Company’s planned U.S. expansion. In the Toronto, Ontario market alone, the number of signed locations has increased by over 50 per cent since the start of 2018.

Glance Technologies, Inc. (GLNNF), closed Thursday's trading session at $0.2898, up 38.00%, on 1,858,852 volume with 539 trades. The average volume for the last 3 months is 435,028 and the stock's 52-week low/high is $0.1517/$3.20.

chart

ULURU, Inc. (ULUR)

Equity Clock, OTC Markets, Innovative Marketing, The Street, Market Screener, GuruFocus, MarketWatch, SmallCapVoice, Zacks, Marketbeat, BabyBulls, Endocrinology Advisor, and TopPennyStockMovers reported earlier on ULURU, Inc. (ULUR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

ULURU, Inc. is a specialty pharmaceutical company headquartered in Addison, Texas. It is focusing on the development of a portfolio of wound management and oral care products. This is to provide patients and consumers improved clinical outcomes through controlled delivery using the Company’s innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system. ULURU lists on the OTC Markets Group’s OTCQB.

ULURU’s strategy is to develop and commercialize a customer-focused portfolio of unique wound care products to treat the different phases of wound healing. In addition, the Company’s strategy involves developing the oral-transmucosal technology and generating revenues via manifold licensing agreements.

ULURU’s Nanoflex® Technology is a new class of material. The design of it is to optimize the wound bed environment and accelerate healing. The Company has its Altrazeal® product. It developed and commercializes Altrazeal® - a transforming powder dressing with proprietary Nanoflex® technology, for the management of exuding wounds. Altrazeal® is a scientifically engineered advanced wound dressing designed to incorporate the desired features and benefits of the ideal wound dressing.

Altrazeal® is produced as a sterile powder and is unique in application and performance on a moist wound surface. Upon application to a moist wound, the powder interacts with wound exudate and hydrates. Hydration with exudate causes the powder to aggregate irreversibly and form a moist wound dressing that conforms to the surface of a wound bed and seals the wound. Altrazeal® has demonstrated potential clinical and economic advantages in numerous chronic and acute wounds.

ULURU has its patented delivery strip for whitening teeth, which completely erodes - the OraDisc™ W- Erodible Whitening Strip for Teeth. This proprietary tooth whitening product comprises a laminated bilayer strip that uses OraDisc™ technology.

Additionally, the Company has its OraDisc™A product. ULURU developed OraDisc™ A, a novel mucoadhesive, water-erodible disc incorporating 2mg of amlexanox, for the treatment and prevention of aphthous ulcers. Moreover, the Company’s OraDisc™ B is a mucoadhesive erodible disc containing 15 mg of benzocaine. It was developed for the treatment of oral pain.

ULURU, Inc. (ULUR), closed Thursday's trading session at $0.075, down 6.25%, on 1,880 volume with 3 trades. The average volume for the last 3 months is 13,520 and the stock's 52-week low/high is $0.0199/$0.10.

chart

NuZee, Inc. (NUZE)

NetworkNewsWire, Stock Orange, Awesome Penny Stocks, Penny Stock Hub, InvestingOnline, OTC Stock Picks, MarketWatch, Barchart, InvestorsHub, Biz Journals, Zacks, OTC Markets, Dividend Investor, Capital Cube, Business Insider, Vending Market Watch, Market Exclusive, Corporate Information, Stockopedia, and Research and Markets reported on NuZee, Inc. (NUZE), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

NuZee, Inc. concentrates on building beverage brands, which offer functional and nutritional benefits. The Company (d/b/a Coffee Blenders®) is the pioneer in functional coffee. It offers gourmet specialty grade coffee in convenient single serve cups using only natural ingredients with clinically supported nutraceuticals. NuZee has its corporate office in Vista, California. Established in 2011, the Company lists on the OTCQB.

NuZee manufactures and sells its Drip Cup line of single serve, pour-over functional coffees. These include Lean Cup® (for weight loss), Think Cup® (for cognitive performance), Relax Cup® (for stress reduction), Active Cup® (for a pre-workout boost of energy), Nude Cup® (100 percent Arabica coffee with no function), and Matcha Cup tea. In addition, NuZee manufactures and sells its Whole Bean coffee line.

NuZee has its ready-to-drink (RTD) gourmet, functional, cold brew coffee line. This product was first available at independent retailers and convenience stores across Southern California. A national roll-out is continuing.

NuZee has undertaken the expansion of its existing production facility in Vista, California. This is to accommodate the growth of its Drip Cup line of functional gourmet coffee sold under the Coffee Blenders® brand name. NuZee adds two new Drip Cup co-packing machines and upgrades process automation as part of the expansion.

NuZee’s customers include B2B (Business-to-Business) multi-store retail chains and wholesale distributors that deliver to chain and independent stores. Also, NuZee sells its products to office and home delivery services that deliver coffee and water to homes and businesses locally.

NuZee earlier announced that it created a new, wholly-owned subsidiary called NuZee KOREA LTD. NuZee KOREA will manage sales, marketing and associated activities for the Coffee Blenders’ line of Drip Cup functional coffees throughout Asia.

This week, NuZee announced that its production facility in Vista, California was awarded Level 2 Safe Quality Food (SQF) Certification by the Safe Quality Food Institute (SQFI). Masa Higashida, Chief Executive Officer of NuZee, said, "The receipt of SQF Certification is a milestone development in NuZee's ongoing efforts to expand our co-packing business for regional and global brands, many of which require SQF Certification as a pre-condition for a relationship. This certification will allow us to advance ongoing conversations with potential clients, establish new sales channels, and support the introduction of new products."  

NuZee, Inc. (NUZE), closed Thursday's trading session at $1.90, up 58.33%, on 110 volume with 1 trade. The average volume for the last 3 months is 94 and the stock's 52-week low/high is $0.25/$1.40.

chart

Rocky Mountain High Brands, Inc. (RMHB)

PennyPickAlerts, Damn Good Penny Picks, SizzlingStockPicks, WallstreetSurfers, Penny Picks, SmallCapVoice, Promotion Stock Secrets, ProTrader, Winston Small Cap, and Fortune Stock Alerts reported previously on Rocky Mountain High Brands, Inc. (RMHB), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Rocky Mountain High Brands, Inc. is a consumer goods business listed on the OTC Markets Group’s OTCQB. The Company’s specialty is brand development of health conscious, hemp-infused, food and beverage products and naturally high alkaline water. Rocky Mountain High Brands has now launched its naturally high alkaline spring water, Eagle Spirit Spring Water. Rocky Mountain High Brands is based in Dallas, Texas.

The Company engages in sales and distribution via online retailers. It presently distributes its products to an array of retail locations, from grocery to convenience to warehouse stores, across the U.S.  Rocky Mountain High Brands employs a hybrid distribution model. This model leverages distribution contacts and brokers, and direct relationships with wholesalers and retailers to expand strategically into new markets.

Currently, the Company markets a lineup of two naturally flavored hemp-infused functional beverages under the name Rocky Mountain High. Regarding its Eagle Spirit Spring Water, it is a naturally high alkaline spring water from a secluded spring at the foot of the ancestral Rocky Mountains.

Moreover, the Company has launched its GPS based geofencing software advertising system in the Los Angeles, California market. Geofencing is the practice of using Global Positioning (GPS) or radio frequency identification (RFID) to define a geographic boundary. The design of the software package is to interface with mobile devices when a consumer is within proximity of a Rocky Mountain High retailer.

This past March, Rocky Mountain High Brands launched its HEMPd product line. At present, it consists of CBD-infused topicals and nutraceuticals. The Company will introduce a line of CBD-infused functional beverages in the fourth quarter.

In July, Rocky Mountain High Brands announced that it acquired all of the assets, trademarks, intellectual property (IP) and ongoing business operations of BFIT Brands, LLC of Phoenix, Arizona. BFIT Brands sells the whey protein and energy drink, FitWhey. FitWhey is an innovative water-based protein drink. It is naturally sweetened, flavored and colored. FitWhey combines the highest quality whey protein isolate with caffeine.

Rocky Mountain High Brands, Inc. (RMHB), closed Thursday's trading session at $0.0118, down 3.28%, on 5,905,735 volume with 129 trades. The average volume for the last 3 months is 9,642,626 and the stock's 52-week low/high is $0.0199/$0.10.

chart

Nemaura Medical, Inc. (NMRD)

OTC Markets, Market Exclusive, and 4-Traders reported on Nemaura Medical, Inc. (NMRD), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Nemaura Medical, Inc. is a medical technology business with its corporate headquarters in Loughborough, England. The Company is developing the wireless sugarBEAT® disposable adhesive skin-patch as a non-invasive, needle-free, pain-free, and affordable continuous glucose monitoring (CGM) system for adjunctive use by diabetics.

Nemaura Medical’s patient-friendly technology has the potential to transform health monitoring through providing real-time, tailored feedback on glucose, lactate, and other important body performance metrics. Nemaura Medical’s shares trade on the NasdaqCM.

Nemaura’s patented BEAT™ technology (passing a mild, non-perceptible electric current across the skin) draws a small number of selected molecules, such as glucose, into a patch placed on the skin. These molecules are drawn out of the interstitial fluid. The patch (via a sensor) measures the amount of that molecule present, converting it into a meaningful concentration value for clinical diagnosis or preliminary guidance for self-treatment.

The BEAT™ technology will allow remote continuous monitoring of chronic diseases and health conditions. It is to replace traditional invasive methods of diagnosis and healthcare observation procedures.

The SugarBEAT® App can be pre-downloaded on a user’s smart device. There is an optional sugarBEAT® handheld reader (applicable where a user chooses not to use their own smart device). sugarBEAT® provides accurate glucose measurement. SugarBEAT® consists of a reusable transmitter containing a daily-disposable adhesive skin-patch.

Nemaura Medical announced in August of 2017 that it signed a non-binding term sheet with Device Technologies for exclusive rights to market and sell sugarBEAT® in Australia and New Zealand. Device Technologies is a leading Medical Device distributor. Nemaura Medical’s expectation is to launch in Australia and New Zealand this year.

At the end of January 2018, Nemaura Medical announced positive summary data for its sugarBEAT® European clinical trial program. The summary results were taken from a 25 patient cohort of the earlier reported European three-stage 75 patient Clinical study, comprising 80 percent Type 1 and 20 percent Type 2 Diabetics.

Results indicate an overall MARD (Mean Absolute Relative Difference) of 13.76 percent over an extensive dynamic glucose concentration range. Up to 70 percent of the data from the study paired between sugarBEAT® and the venous blood glucose concentration attained an average MARD of 10.28 percent, denoting even more accuracy. A MARD of 10 percent is considered to be sufficient for making therapeutic decisions. No serious or major device related adverse events were noted.

At the beginning of March, Nemaura Medical announced that it started expansion into new manufacturing facilities. This will allow large scale production of the Company’s proprietary sensor technology.

Nemaura Medical, Inc. (NMRD), closed Thursday's trading session at $3.43, up 19.93%, on 1,098,350 volume with 2,681 trades. The average volume for the last 3 months is 105,059 and the stock's 52-week low/high is $2.049/$6.80.

chart

Millennial Lithium Corp. (MLNLF)

Streetwise Reports, TradingView, OTC Markets, TipRanks, Insider Financial, Stockwatch, Junior Mining Network, Morningstar, Small Cap Leader, Stockpulse, The Street, Penny Stock Tweets, Investing News, Barchart, Stockhouse, 4-Traders, Metals News, Investors Hub, and Zacks reported on Millennial Lithium Corp. (MLNLF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Millennial Lithium Corp. is an emerging exploration and development company listed on the OTC Markets’ OTCQX. The Company is concentrating on world class lithium assets in Argentina. Its dedication is to advancing the Pastos Grande Lithium project and the Cauchari East lithium project. Millennial Lithium has its corporate office in Vancouver, British Columbia.

The Company controls more than 35,000 hectares of claims in the heart of the Lithium Triangle. The Lithium Triangle is home to the world’s most prolific lithium deposits.

The Pastos Grandes Project is Millennial Lithium’s flagship project. This Project is in Salta Province, Argentina. At present, the Pastos Grandes Project encompasses 6,361 hectares. This makes Millennial Lithium the most active company in this expansive salar.

The Company has an option to acquire 100 percent of the Pastos Grandes Lithium Project. The timeline to production is three years and 9 wells have been drilled and $9 Million spent in development.

On December 21, 2017, Millennial Lithium entered into the final agreement with the Salta Provincial Energy and Mining Company (REMSA) for the acquisition of 2,492 hectares of claims strategically positioned in the Pastos Grandes Salar and neighboring the Company’s present land holdings there. Completion of this acquisition brings Millennial Lithium’s holdings at Pastos Grandes to 8,664 hectares.

The Cauchari East Project is one of the world’s most prospective, shovel-ready lithium brine development projects. It is at the core of the Lithium Triangle.

Millennial Lithium is working towards the completion of a 43-101 resource calculation. The ready availability of plenty of regional mining infrastructure offers the prospect of lowered Capex (capital expenditures) and operational expenditures at Cauchari East.

Recently, Millennial Lithium announced that there has been major progress on its flagship Pastos Grandes Project in Salta, Argentina. The Company initiated many studies in support of its continuing basic engineering and Feasibility Study (FS) recently initiated by WorleyParsons Chile.

Farhad Abasov, Millennial Lithium’s President and Chief Executive Officer, said, "We are very pleased with the progress at our Pastos Grandes Project. WorleyParsons is advancing the Pastos Grandes Feasibility Study which remains on schedule for completion in Q1 2019. Technical studies in support of the Feasibility Study, including exploration drilling, pumping well tests and geophysics are well underway on the REMSA license that comprises part of the Pastos Grandes Project…”

This week, Millennial Lithium reported positive drilling and analytical results from the latest complete exploration wells at its Pastos Grandes Project in Salta, Argentina. All four new exploration holes (PGMW18-12—15) completed so far have terminated in thick lithium-bearing brine zones. Hole 15 intersected lithium grades reaching up to 500 mg/L Li with the lithium horizon displaying a thickness of 236 meters.

Exploration holes PGMW18-12, PGMW18-13, PGMW18-14 and PGMW18-15 were drilled to depths of 554 meters (m), 559m, 635m and 594m, respectively. All wells terminated in brine-bearing sand.

Millennial Lithium Corp. (MLNLF), closed Thursday's trading session at $1.39437, up 0.53%, on 11,258 volume with 18 trades. The average volume for the last 3 months is 26,900 and the stock's 52-week low/high is $1.07/$3.8694.

chart

Acorn Energy, Inc. (ACFN)

Wall Street Resources, Wealthpire, Inc., SmarTrend Newsletters, MegaPennyStocks, Catalyst IR, Marketbeat.com, and Hit and Run Candle Sticks reported earlier on Acorn Energy, Inc. (ACFN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Acorn Energy, Inc. is a holding company based in Wilmington, Delaware. It is a provider of machine-to-machine, Internet of Things (IoT) remote monitoring and control systems and services. Acorn has two portfolio companies. These are OmniMetrix™, Inc. and DSIT Solutions Ltd.

The Company has an 80 percent equity stake in OmniMetrix. Acorn consolidates its assets, liabilities and results of operations. Acorn has a 41.2 percent equity stake in DSIT Solutions, which it accounts for under the equity method.

Acorn Energy’s OmniMetrix™ remotely monitors emergency back-up power generation systems to increase their reliability. OmniMetrix™ is the leader and pioneer in M2M wireless remote monitoring, control and diagnostics for pipelines and critical equipment.

OmniMetrix is a solution for making critical systems more reliable. The Company is a solution for pipelines and critical facilities around the world. This includes cell towers, medical facilities, data centers, public transportation systems, and federal, state, and municipal government facilities.

Acorn Energy’s DSIT Solutions provides security solutions from underwater threats to naval and marine based energy assets. DSIT Solutions specializes in the science of sonar and underwater acoustics. It develops advanced Acoustic Intelligence (ACINT) measurement and analysis applications. The Company’s Shield™ family of Underwater Security Systems provides automatic Diver Detection Sonars for protection of valuable coastal and offshore sites.

This past November, Acorn Energy announced results for its Q3 ended September 30, 2017. The Company’s financial results reflect the deconsolidation of DSIT’s operating results following the sale of a portion of Acorn’s ownership in April 2016. DSIT’s operating results were fully consolidated for the period January 1 through April 21, 2016.

Because of the growth in its OmniMetrix subsidiary, Acorn Energy’s Q3 2017 Revenue rose 15 percent to $1,085,000 from $942,000 in Q3 2016. Mainly reflecting the impact of the DSIT deconsolidation in April of 2016, Acorn Energy’s Revenue for the first nine months of 2017 decreased to $3,226,000 from $7,618,000 in the comparable 2016 period. First nine months’ Revenue included $5,074,000 of DSIT revenue in 2016.

The Company reported Q3 2017 Net Income attributable to Shareholders of $236,000, or $0.01 per share. This is in comparison to Net Income of $652,000, or $0.02 per share, in Q3 of 2016.

Acorn Energy, Inc. (ACFN), closed Thursday's trading session at $0.325, up 1.53%, on 4,900 volume with 7 trades. The average volume for the last 3 months is 31,129 and the stock's 52-week low/high is $0.149/$0.4499.

chart

AXIM Biotechnologies, Inc. (AXIM)

TopPennyStockMovers, CFN Media Group, Promotion Stock Secrets, and SmallCapVoice reported earlier on AXIM Biotechnologies, Inc. (AXIM), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

AXIM Biotechnologies, Inc. is a biotechnology company focusing on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. The Company discovers and brings to market innovative solutions via research and development (R&D), strategic partnerships, and acquisitions through setting the green standard in the industrial hemp industry. Medical Marijuana, Inc. is a major investor in AXIM. AXIM Biotechnologies is headquartered in New York, New York.

The Company’s emphasis is on unique proprietary delivery mechanisms for the introduction of cannabinoids and finding solutions for conditions for which there is presently no effective treatment. AXIM is advancing its patented controlled-release cannabinoid gum in studies encompassing a number of indications. AXIM’s flagship CanChew Plus® contains 10mg of cannabidiol (CBD) obtained from industrial hemp plants.

AXIM’s pipeline of Intellectual Property (IP) protected cannabinoid-based products additionally include MedChew Rx™. This THC/CBD cannabinoid controlled-release chewing gum is to address pain and muscle spasticity in multiple sclerosis (MS) patients. This pioneering invention is on course to be fully registered by the EMA and the Food and Drug Administration (FDA) by the end of 2017. It is the world’s first patented cannabinoid controlled-release chewing gum.

In addition, AXIM’s products include RENECANN™ - the world’s first cannabigerol (CBG)-based skincare product line. Moreover, its products include ORAXIMAX™ - the world’s first CBG-based oral care product line; Suppocann™ - a suppository cannabinoid-release product for GI conditions including IBD, IBS and Crohn’s disease; and Ophthocann™ and Cannbleph™ - cannabinoid-based products for the reducing of intraocular pressure and for the relief of conjunctivitis.

The Company’s IP portfolio now includes two fully issued patents – one patent permitting the use of CBD (cannabidiol) in controlled-release, functional chewing gum, and another patent for chewing gum containing natural and synthetic cannabinoids for the treatment of pain, and 15 patent applications in different stages of approval.

In November,  AXIM® Biotechnologies announced clinical trial results from its first Phase II pilot trial for the treatment of irritable bowel syndrome (IBS) with its CanChew +® CBD (cannabidiol) functional, controlled release chewing gum. The study was conducted at Wageningen University in The Netherlands. It was a randomized, placebo controlled, double-blind, cross-over trial aimed at investigating acceptance and overall pain reduction.

Study results indicate that CanChew+® was well tolerated by the IBS patients. In addition, no significant adverse side effects were observed by any participants of the trial. All patients who participated in the study experienced decrease in their levels of pain score.

Earlier this month, AXIM® Biotechnologies announced that it successfully completed a pre-investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) for a dronabinol-based functional, controlled-release chewing gum product the Company is developing to help treat patients with chemotherapy-induced nausea and vomiting and HIV/AIDS patients experiencing appetite and weight loss. AXIM will now start preparing its IND filing to the FDA for this new chewing gum product, referencing Marinol®, one of the FDA-approved, dronabinol-based drugs available in the United States.

AXIM Biotechnologies, Inc. (AXIM), closed Thursday's trading session at $1.99, down 0.50%, on 130,987 volume with 223 trades. The average volume for the last 3 months is 82,678 and the stock's 52-week low/high is $1.70/$10.29.

chart

Impala Platinum Holdings Limited (IMPUY)

Zacks, MarketWatch, Ceo.ca, GuruFocus, Marketbeat, YCharts, OTC Markets, Equity Clock, Investopedia, and The Street reported on Impala Platinum Holdings Limited (IMPUY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Impala Platinum Holdings Limited is a foremost producer of platinum and associated platinum group metals (PGMs). The Company is structured around five mining operations and Implats Refining Services, which is a toll refining business. The Company’s operations are situated on the Bushveld Complex in South Africa and the Great Dyke in Zimbabwe.

Impala Platinum Holdings is headquartered in Johannesburg, South Africa. The Company is Implats Platinum Limited’s 96 percent-owned main operational unit. Impala Platinum Holdings’ shares trade on the OTC Markets Group’s OTCQB.

The Company operates via Mining Operations, Refining Services, Chrome Processing, and Other segments. Impala Platinum Holdings produces platinum, palladium, rhodium, and nickel.

Impala has operations on the western limb of the world-renowned Bushveld Complex near Rustenburg, South Africa. This operation consists of a 13 shaft mining complex and concentrating and smelting plants. The base and precious metal refineries are in Springs, east of Johannesburg.

At the beginning of this month, Impala Platinum Holdings announced it delivered an improved performance at most operations for the half year ended December 31, 2017. The Company reported a Gross Profit of R733 million for the period, versus a Gross Loss of R139 million for the previous comparable period.

The Company’s improved operating performance resulted mainly from efficiencies at Impala Rustenburg, a strong operational turnaround at Marula, and a sustained performance from Zimplats. This resulted in an improved headline Loss per Share of 21 cents. This is a 70.4 percent improvement over the prior period.

Group tonnes milled rose by 7.4 percent from 9.3‐million tonnes to 9.9‐million tonnes. Increased production volumes from operations were supported by higher deliveries from third-party toll refining customers.

This yielded a 13.3 percent increase in platinum in concentrate from 766,200 ounces to 867,800 ounces. There was a 9.4 percent increase in platinum in concentrate contribution from Impala Rustenburg.

Impala Platinum Holdings Limited (IMPUY), closed Thursday's trading session at $1.195, up 5.75%, on 31,250 volume with 24 trades. The average volume for the last 3 months is 50,914 and the stock's 52-week low/high is $1.10/$3.22.

chart

Lion One Metals Limited (LOMLF)

StreetWise Reports, TopStocks, Barchart, Stockhouse, Stock Twits, Investors Hub, OTC Markets, Junior Mining Network, MarketWatch, Morningstar, Nasdaq.com, Canadian Mining Report, ‎ Investor Ideas, TradingView, Mining Atlas, Mining.com, Stock World, and Investing.com reported on Lion One Metals Limited (LOMLF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

A mineral exploration and development company, Lion One Metals Limited concentrates on advancing to production at its 100 percent owned and fully permitted high grade underground Tuvatu Gold Project. Tuvatu is positioned on the island of Viti Levu in the Republic of Fiji.

Lion One Metals has its corporate headquarters in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQB. Lion One Metals also has an office in Fremantle, Australia and in Waimalika, Nadi, Republic of Fiji.

Lion One Metals was created upon the completion of a reverse takeover (RTO) between X-Tal Minerals Corp. and American Eagle Resources, Inc. on January 31, 2011.

The Company is centered on cost effective and environmentally responsible construction, development, as well as advancement of Tuvatu towards production. This is tied with exploration of the Company’s district-scale license areas encompassing the highly prospective and underexplored Navilawa volcano.

Lion One Metals is advancing Tuvatu as a near-term production opportunity with exploration upside in the southwest Pacific Ring of Fire. The Company has modeled Tuvatu for exploration after regional giants in the low sulphidation family of high grade epithermal gold deposits, including Porgera and Lihir in Papua New Guinea, and Vatukoula in Fiji that boast production of more than 35 million ounces of gold in alike alkaline volcanic settings.

Tuvatu is the largest undeveloped gold project in Fiji. Moreover, it is one of the highest grade gold projects anywhere globally. The Company is focused on building production of 100,000 oz. annually over 10 years. Lion One Metals holds a 200 km² exploration license package encompassing the entire Navilawa volcano, with the Tuvatu mining lease at its center.

In February, Lion One Metals announced that an expansive surface exploration program has started at its high grade Tuvatu Gold Project. The 2018 surface program will be carried out within the permitted area of the Tuvatu Mining Lease (SML 62). It will consist of Phase One that includes excavator benching with detailed mapping and sampling, followed by a Phase Two drilling program.

In addition, last month, Lion One Metals announced that a surface sample of 502 g/t gold over 0.70 meters was returned from the Jomaki prospect 1 km from the planned mill site at its Tuvatu Gold Project, now in the development stage.

The high grade assay result was returned from bench sampling. It extends the Jomaki prospect, positioned 1,300 meters south-west of the primary mineralized zone at Tuvatu, and 1 km south-west of the planned mill site.

At the Tuvatu Gold Project, bulk earthworks are progressing in all plant site areas. Additionally, clearing and grubbing are substantially complete. Two rock crushing plants are presently in operation for the production of gabion wall rock and engineered fill for construction of the plant facility platforms. Detail engineering continues on the process plant, infrastructure, and also tailings storage facility. Lion One Metals continues metallurgical test work on high pH leach pretreatment methods to improve gold recovery.

Lion One Metals Limited (LOMLF), closed Thursday's trading session at $0.36573, up 5.40%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 5,526 and the stock's 52-week low/high is $0.347/$0.615.

chart

HealthLynked Corp. (HLYK)

InvestorsHub and OTC Markets reported on HealthLynked Corp. (HLYK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, HealthLynked Corp. focuses on improving healthcare services for patients and physicians. The Company’s technology cuts wait times with online scheduling of appointments and real-time appointments by local providers. Its technology also provides easy access to an individual’s and their family's updated medical records. HealthLynked is headquartered in Naples, Florida. The Company commenced trading on the OTC Markets Group’s OTCQB in May 2017.

HealthLynked centers on improving healthcare through connecting patients with their healthcare providers. The HealthLynked Network focuses on the efficient, secure exchange of medical information between patients and their healthcare providers.

The cloud-based HealthLynked Network lets patient's medical records move with them. This is so one’s medical records are not fragmented in manifold healthcare systems and/or EHR systems.

HealthLynked profile information safeguards that doctors don't prescribe potentially harmful medications in case a patient forgets to mention one or more present medications while talking to their doctor. Moreover, the HealthLynked Healthcare Summary page allows patients to keep their medical records updated. This helps physicians to be more productive and provide valid medical care.

Healthcare experts can easily be in touch with patients. They can provide their advice in case of emergencies via the Telemedicine Portal. The HealthLynked Healthcare Summary permits patients to maintain a complete medical profile in coordination with physicians. All information is systematically categorized. As a result, physicians have a total overview of patient health without them having to fill unnecessary paperwork.

This past September, HealthLynked announced it has created more than 880,000 HealthLynked Provider base profiles for every physician in the United States. The creation of the HealthLynked provider network is a vital step in allowing the Company’s patient members to search, geo-locate, and ultimately "Lynk" to any healthcare provider anywhere in the U.S.

Last month, HealthLynked announced its Q3 2017 financial results. It reported revenue of $480,723, and an operating loss of $512,153, which included roughly $135,500 of legal, accounting and other expenses related to the Company’s continuing public filings and investor relations cost and about $158,500 of incremental salary, benefits and other costs related to investment in initial sales and marketing efforts, and software development of the HealthLynked Network.

This was offset by a decrease in Naples Women’s Center’s general and administrative expenses of roughly $45,000, versus Q3 of 2016. The results compare with revenue of $516,798 and an operating loss of $482,570 in Q2 of 2016.

HealthLynked Corp. (HLYK), closed Thursday's trading session at $0.22, up 20.55%, on 393,325 volume with 72 trades. The average volume for the last 3 months is 257,522 and the stock's 52-week low/high is $0.0299/$0.6499.

chart

Thin Film Electronics ASA (TFECY)

OTC Markets, YCharts, Stockwatch, Penny Stock Hub, Current Charts, Street Insider, MarketWatch, Dividend Investor, Morningstar, Market Screener, The Street, Marketbeat, InvestorsHub, Business Wire, TradingView, Stockhouse, Wallet Investor, and Investors Hangout reported on Thin Film Electronics ASA (TFECY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Thin Film Electronics ASA is an international leader in NFC (near field communication) mobile marketing solutions. The Company is enabling the Internet of Everything by way of its NFC solutions. Thin Film Electronics has its worldwide headquarters in Oslo, Norway; its U.S. headquarters in San Jose, California; and offices in Linköping, Sweden; San Francisco; London; Hamburg; Singapore; and Shanghai. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Thin Film Electronics’ mission is to deliver solutions that take advantage of mobile devices as intelligent agents to help create and connect the Internet of Everything. In addition, its mission is to create printed integrated systems utilizing unique, high-volume processes to deliver scale advantages over conventional electronics.

Thin Film Electronics provides consumer-centered NFC mobile marketing and industrial and supply chain solutions. These include blockchain applications. The Company provides end-to-end support throughout the whole process.

This begins with the manufacturing of NFC tags via its pioneering, roll-to-roll printed electronics production process, integration support to get the tags on physical objects, and the Company’s CNECT™ cloud-based software platform that captures data and provides actionable insights into consumer behavior and business logistics.

Thin Film Electronics creates printed tags, labels, and systems that include sensors and wireless communication. It offers end-to-end mobile marketing solutions. These solutions feature hardware, label/packaging integration services, and comprehensive cloud-based reporting and analytics.

The Company’s NFC Solutions are optimized for consumer and industrial applications. This includes its OpenSense™ Technology - Dual-ID tag with sealed/opened sensor. It features authentication and refill fraud protection. Its solutions also include SpeedTap™ Technology - Single-ID tag. It features instant product authentication and targeted marketing and track & trace capabilities.

Recently, Thin Film Electronics ASA announced a collaboration with Clause, the leading provider of “smart” legal contracting technology. Via this collaboration, Clause and Thin Film will use NFC to facilitate the pairing of physical goods to digital contracts through the tap of a smartphone.

The resulting connection will deliver important functional and efficiency improvements for customers across the Clause “connected contracting” platform. Thin Film Electronics will integrate Clause’s connected contracting solution with the CNECT™ Cloud Platform. This will make it available to existing and prospective customers interested in "smart" legal contracts.

Thin Film Electronics ASA shipped greater than 5 million EAS (electronic article surveillance) anti-theft tags to its go-to-market partner during Q2. The Q2 shipments included the first volume orders reserved for use in the denims category.

Thin Film Electronics ASA (TFECY), closed Thursday's trading session at $1.45, up 28.32%, on 38,440 volume with 21 trades. The average volume for the last 3 months is 6,634 and the stock's 52-week low/high is $1.029/$3.90.

chart

Khiron Life Sciences Corp. (KHRNF)

Penny Stock Hub, Stockwatch, Stockhouse, Midas Letter, Barchart, Morningstar, Proactive Investors, MarketWatch, Investors Hangout, Wallmine, OTC Markets, Wallet Investor, Investing News, Capital Network, InvestorsHub, Pot Network, Market Screener, GuruFocus, and TradingView reported on Khiron Life Sciences Corp. (KHRNF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Khiron Life Sciences Corp. is a Canadian integrated medical cannabis company listed on the OTCQB. It has its core operations in Colombia. Khiron is fully licensed in Colombia for the cultivation, production, domestic distribution, and worldwide export of tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis. Khiron Life Sciences has its corporate headquarters in Toronto, Ontario and an office in Bogota, Colombia.

Khiron combines international scientific expertise, agricultural advantages, branded product market entrance experience and education to grow prescription and brand loyalty to address priority medical conditions including chronic pain, epilepsy, depression and anxiety in the Latin American market. The Company is creating research partnerships with some of Colombia’s foremost medical associations – the Colombian Association of Neurology being one of them.

Moreover, Khiron has the advice of the best laboratories from Israel and Canada in genetics and, production and clinical data of medical cannabis. Regarding the cultivation process and product development, it has developed a temperature, humidity, and air circulation control system that ensures that the plant grows in a controlled natural environment. The Company’s cultivation is hydroponic.

In August, Khiron Life Sciences announced that it notified the Colombian Ministry of Justice that it expanded its cultivation area to 17.5 hectares of prime agricultural land near Ibague, Colombia . The cultivation site has an ideal climate profile, and an abundance of water, power, and skilled labor to scale cultivation and production. The cultivation region is in a highly secure area of Colombia.

Yesterday, Khiron Life Sciences announced that it closed its earlier announced best efforts short form prospectus offering of common shares, including the exercise in full of the over-allotment option. A total of 14,375,000 Common Shares were sold at a price of $0.90 per Common Share for aggregate gross proceeds of $12,937,500 (including the exercise in full of the over-allotment option). The expectation is that the net proceeds of the Offering will be used by Khiron to fund its facility expansion, equipment purchases, clinic construction, its cosmeceutical product line launch and general working capital purposes.

Khiron Life Sciences Corp. (KHRNF), closed Thursday's trading session at $0.9324, down 8.59%, on 462,307 volume with 287 trades. The average volume for the last 3 months is 79,337 and the stock's 52-week low/high is $0.6637/$1.555.

chart

Bitcoin Investment Trust (GBTC)

Stock Twits, Zacks, CryptoCurrencyFacts, Stock Investor, Street Insider, Strategic Coin, Investopedia, Morningstar, MarketWatch, SlashGear, Stockhouse, Finance Registrar, TradingView, Bitcointalk, The Street, Business Insider, Investor Place, MintDice, Wallet Investor, Brave New Coin, and Cointelegraph reported on Bitcoin Investment Trust (GBTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Grayscale Investments, LLC is an authority on digital currency investing. The Company provides secure access to the digital currency asset class by way of its single-asset and diversified investment products. These include Bitcoin Investment Trust™ (GBTC) and Digital Large Cap Fund™. Formed in 2013 by Digital Currency Group, Grayscale Investments is headquartered in New York, New York. The Company lists on the OTC Markets Group’s OTCQX.

Bitcoin Investment Trust™ is a privately offered trust. It is available solely to accredited investors. Bitcoin Investment Trust’s investment goal is for the value of its shares to reflect the price performance of bitcoin, minus fees and expenses. Bitcoin Investment Trust was established for investors looking for exposure to bitcoin via a traditional investment vehicle.

Bitcoin Cash Investment Trust™ is a privately offered trust. It is available exclusively to accredited investors. Bitcoin Cash Investment Trust’s investment goal is for the value of its shares to reflect the price performance of Bitcoin Cash (BCH), minus fees and expenses. Bitcoin Cash Investment Trust was established for investors looking for exposure to BCH through a traditional investment vehicle.

Last week, Grayscale Investments announced the launch of Zen Investment Trust. This is a single-asset investment vehicle solely consisting of ZEN, a privacy-focused digital currency.

Zen Investment Trust is the eighth single-asset investment product introduced by Grayscale. In addition, it is the first security solely invested in ZEN. Further to its single-asset products, Grayscale Investments also manages the above-mentioned Digital Large Cap Fund™. This is a diversified investment product, which provides exposure to the leading digital currencies by market capitalization.

ZEN is a privacy-oriented digital currency. It is native to Horizen (previously ZenCash), a decentralized technology platform that provides users with total control of their digital footprint.

Mr. Michael Sonnenshein, Managing Director of Grayscale Investments, said, "We've been very impressed with the Horizen team and its vision for ZEN as a leading privacy coin. Grayscale is at the forefront of asset management in this emerging industry, and we will continue to offer our clients access to the most interesting blockchain projects in the world."

Bitcoin Investment Trust (GBTC), closed Thursday's trading session at $8.69, up 5.46%, on 1,412,433 volume with 2,504 trades. The average volume for the last 3 months is 2,363,095 and the stock's 52-week low/high is $5.2857/$38.7142.

chart

The QualityStocks Company Corner

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)

The QualityStocks Daily Newsletter would like to spotlight Standard Lithium Ltd. (OTC: STLHF).

Consumers are switching to electric vehicles faster than previously thought, making an expected boom in demand for battery-grade lithium ever more real. Standard Lithium (TSXV: SLL) (OTC: STLHF) stands to profit as they bring new supplies online.

Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.

The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.

“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”

Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.

LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.

Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.

The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.

Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.

Market Opportunity

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.

Leadership

Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.

Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.

The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.

Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.

Standard Lithium Ltd. (OTC: STLHF), closed the day's trading session at $1.22, up 18.45%, on 339,240 volume with 220 trades. The average volume for the last 3 months is 29,485 and the stock's 52-week low/high is $0.604/$2.23.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

PressureBioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in thedevelopment and sale of broadly enabling, pressure-based instruments, consumables,and platform technology solutions to the worldwide life sciences industry,today announced the sale of the first two instruments from its newest line ofhigh-pressure based instrument systems, the HUB880 Explorer.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.95, up 12.86%, on 1,965 volume with 10 trades. The average volume for the last 3 months is 1,753 and the stock's 52-week low/high is $2.70/$5.00.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, has announced that its Chief Executive Officer, Steve Wallach, has been appointed to the Direct Selling Association (DSA) Board of Directors. Also today, CannabisNewsWire released an Audio Press Release (APR) titled “CBD Contributes to Continued Growth for Nutraceutical, Pharmaceutical and Cannabis Key Players,” featuring Youngevity International. To hear the CannabisNewsAudio version, visit: http://cnw.fm/6mZZM. To view the full editorial, visit: http://cnw.fm/RbM2b.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $4.17, up 7.20%, on 51,790 volume with 174 trades. The average volume for the last 3 months is 18,373 and the stock's 52-week low/high is $3.1674/$6.75.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company (the “Company”), announced that it has sent a notice to H.C. Wainwright & Co., LLC (“HCW”) terminating the At Market Issuance Sales Agreement, dated February 27, 2018 (the “Agreement”), by and between itself and HCW. The effective date of the termination is September 23, 2018.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.4675, up 6.52%, on 1,062,975 volume with 1,912 trades. The average volume for the last 3 months is 1,818,760 and the stock's 52-week low/high is $0.3889/$5.9499.

Recent News

chart

NUGL Inc. (NUGL)

The QualityStocks Daily Newsletter would like to spotlight NUGL Inc. (NUGL).

Despite the U.S. federal government’s reluctance to legalize cannabis over the past several years or even encourage its use in scientific research, the medical marijuana industry has grown state-by-state and in other countries, along with a burgeoning acceptance of recreational marijuana use to such a point that consumers have become acquainted enough with cannabis to develop preferences for specialty strains and outlets. That consumer development parallels growing diversification within the cannabis industry, as companies step forward to fill a variety of service and product needs, and that, in turn, has created a niche for an enterprising cannabis industry search engine company named NUGL Inc. (OTC: NUGL).

NUGL Inc. (NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.

Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.

“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”

NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.

“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”

Leadership Team

NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.

“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”

NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.

CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.

Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-­looking software for various industries.

NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.

Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.

NUGL Inc. (NUGL), closed the day's trading session at $1.50, up 12.78%, on 342,524 volume with 445 trades. The average volume for the last 3 months is 125,500 and the stock's 52-week low/high is $0.405/$1.799.

Recent News

chart

Cannabis Strategic Ventures, Inc. (NUGS)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Strategic Ventures, Inc. (NUGS).

Cannabis Strategic Ventures, Inc. (OTC: NUGS) is pleased to announce a joint venture agreement with True Promise Beauty to develop a new skincare line infused with cannabidiols (CBD). Under the terms of the agreement, Cannabis Strategic Ventures will have access to True Promise Beauty’s proprietary hemp derived CBD infused formulas and products and access to established distribution channels. Also today, the company was highlighted in an article on the massive impact of CBD on the healthcare product industry, which continues to be widely apparent as consumers increasingly show a preference for alternative methods of medicine. A new report by the Brightfield Group estimates the CBD market is growing at a faster rate than anticipated, reaching sales of $22 Billion by 2022.

Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.

The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.

Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.

Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.

Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.

Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.

Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.

The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.

Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $4.765, up 8.54%, on 215,708 volume with 523 trades. The average volume for the last 3 months is 91,217 and the stock's 52-week low/high is $0.0309/$7.13.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (SGMD) was highlighted today in an article on the massive impact of CBD on the healthcare product industry, which continues to be widely apparent as consumers increasingly show a preference for alternative methods of medicine. A new report by the Brightfield Group estimates the CBD market is growing at a faster rate than anticipated, reaching sales of $22 Billion by 2022.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.122, up 4.59%, on 3,889,863 volume with 495 trades. The average volume for the last 3 months is 1,086,390 and the stock's 52-week low/high is $0.028/$0.430.

Recent News

chart

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Biotechnology company Earth Science Tech Inc. (OTCQB: ETST) yesterday announced that it has been approved for uplisting to the OTCQB Venture Market. To view the full press release, visit: http://cnw.fm/n75oI. Also today, CannabisNewsWire released a report on the company detailing how ETST has taken another major step in its mission to become a global leader in the research, development and sale of hemp-derived, CBD-based pharmaceuticals, nutraceuticals and dietary supplements, amid the ongoing surge in cannabinoid therapeutics.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.80, up 5.33%, on 53,670 volume with 57 trades. The average volume for the last 3 months is 12,990 and the stock's 52-week low/high is $0.324/$1.62.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Amid concerns worldwide about the deleterious effects of pollutants on the planet’s ecosystems, oil and gas industry players such as Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) continue building the visibility of their efforts to be environmentally conscious, and Petroteq’s current real-time rollout of proprietary technology that will extract oil in a closed-loop, zero-harm process puts it in a vanguard position for touting energy and environmentalism’s compatibility.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $1.09, up 0.93%, on 261,864 volume with 184 trades. The average volume for the last 3 months is 396,145 and the stock's 52-week low/high is $0.2899/$1.8892.

Recent News

chart

Canopy Rivers Corporation

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Corporation.

Canopy Rivers Corporation, the VC arm of Canopy Growth (TSX: WEED, NYSE: CGC), and AIM2 Ventures Inc. (TSXV: AIMB.P) (“AIM2”) recently announced that the shareholders of the respective companies have voted in favor of all matters concerning the companies’ business combination that will result in in a reverse take-over (“RTO”) of AIM2 by Canopy Rivers.

Canopy Rivers Corporation is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Recent News

WhereverTV Broadcasting Corp. (TVTV)

The QualityStocks Daily Newsletter would like to spotlight WhereverTV Broadcasting Corp. (TVTV).

WhereverTV Broadcasting Corp. (OTCQB: TVTV) is a next-generation OTT (over-the-top) television subscription service that manages livestream broadcast programming rights across multiple devices, geographies and languages. WhereverTV’s prepaid, no-contract, subscription television services are delivered to a variety of devices including AppleTV, Amazon Fire TV Stick, Google Chromecast, smartphones, Tablet PCs, streaming media players, computers and connected TVs.

WhereverTV Broadcasting Corp. (TVTV) is a next-generation OTT (Over-the-top) television subscription service that manages live-stream broadcast programming rights across multiple devices, geographies and languages, providing viewers with personalized service that is truly “wherever” they may be watching TV.

WhereverTV’s patented Interactive Program Guide (IPG) technology currently handles over 125 live channels that are broadcasted securely over the Internet to any Internet-enabled device anywhere in the world. Many of the company’s channels are the same as those broadcasted by traditional cable and satellite companies. For example, the World News Now package includes One America News, RT News (Russia Today), Bloomberg TV, CBN News and EuroNews Live — the latter provides pan-European coverage in 350 million households in 155 countries. Other channel packages include Choice TV (a wide variety of popular options for the family), Spanish TV, Faith TV and Morocco TV, providing current genre-specific subscriptions for news, faith, drama, sports, movie, reality and children’s programming.

WhereverTV’s free app works with iOS and Android devices to cover the spectrum of mobile consumer needs, as well as with personal desktop or laptop computers through its over the top (OTT) platform. The platform delivers channels, shows and events to SmartTVs and digital media receivers that include Google Chromecast, AppleTV, Amazon Fire TV, iPhone, iPad, Android Smartphone and TabletPCs, with DVR recording functionality slated for future development.

The company, based in Fort Myers, Florida, was developed in 2007 as a solution to its founder’s frustration with the complexities of trying to stream English speaking content while abroad. As the live-streaming market has developed over the decade since then, WhereverTV has gained recognition as a pioneer in next-generation content delivery systems.

WhereverTV’s strategy is to increase revenue-generating subscriptions worldwide through the acquisition of content that is desirable to consumers and deliverable anywhere a device can connect to the Internet. Prepaid accounts will be accessed through the cloud, and the IPG technology will allow users to make their viewing choices. The company has developed two separate divisions, one for worldwide distribution and one for Latin American distribution.

In 2017, the company acquired Digital Rodeo, LLC, a Tennessee limited liability company that delivers a rich mixture of music and videos from independent country artists, current arrests and legacy artists, as well as similar Florida-based companies Digital RodeoTV, LLC (Name changed to WhereverTV Country in 2018), Digital CrossTV, Inc., Digital PopTV, Inc., and Digital RockTV, Inc.

WhereverTV is transitioning from a development to operational company and in doing so we have refined our 2018 business model,” CEO Edward D. Ciofani stated. “Our business model calls for content acquisition from around the world, exclusive content development, Major Marketing Alliances, similar to the announced Google Chromecast for Latin America and major marketing initiatives including social media marketing. … There are a lot of content providers (channel providers) around the world that offer a uniquely diversified perspective of cultures, travel and lifestyle content.”

As an increasing number of people “Cord-Cutters” no longer subscribe to the traditional cable or satellite distribution but rather a simpler lower cost means of watching content. The streaming OTT industry is expected to grow to $62 billion by 2020 — nearly triple its revenues in 2015, per Goldman Small Cap Research. Future Market Insights estimated the North America OTT market alone at $16.29 billion in 2017 with a CAGR of 17.4 percent through 2028. The arrival of 5G technology this year has the potential to accelerate the pace.

WhereverTV Broadcasting Corp. (TVTV), closed the day's trading session at $0.06, even for the day. The average volume for the last 3 months is 26,571 and the stock's 52-week low/high is $0.041/$0.460.

Recent News

chart

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF)

The QualityStocks Daily Newsletter would like to spotlight Koios Beverage Corp. (KBEVF).

Koios Beverage Corp. (CSE:KBEV)(OTC: KBEVF) (the "Company" or "Koios") is pleased to announce it has entered into a distribution agreement with Western Functional Beverages, a leading distributor of healthy, functional drinks targeting the fitness crowd in the State of Wyoming.

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) develops and distributes nature-based products that boost brain function, enhance health, and improve productivity. Its core vision is to help a billion people worldwide live more productively through the development of nootropics, which are supplements that improve cognitive abilities.

The company’s flagship product, Koios, is a GMP-certified dietary supplement. Made from natural ingredients and backed by science, Koios is designed to improve focus, memory, mental drive, clarity and energy. The company produces Koios in the following formulations:

  • Powder supplements containing nootropics as well as caffeine and lion’s mane and chaga mushrooms;
  • Vegan-friendly capsules;
  • Canned beverages containing nootropics along with MCT oil to burn fat and increase metabolism.

Not to be mistaken with prescription-only drugs which are at times used for similar effects, nootropics are over-the-counter dietary supplements; some of which, like Koios, contain ingredients that are currently used in the treatment of patients with Alzheimer’s disease. The global field of nootropics is growing rapidly and expected to reach USD $6,059.4 Mn by 2024 with a CAGR of 17.9 percent from 2016 to 2024.

According to media reports, there is believed to be significant and growing use of nootropics among high-achieving students and professionals. The UK’s leading Guardian newspaper found that nootropics are commonly used in Silicon Valley by computer industry professionals who want to “hack” their minds and maximize their productivity without any possible negative effects on the brain.

Koios was born out of the personal struggles of its founder and CEO, Chris Miller, who has ADHD. Miller found that the symptoms of his condition held him back when navigating the competitive modern workplace. Unhappy with the effects of the Adderall he was prescribed, Chris began a search for a natural remedy that would improve his attention and mental capacity.

Speaking of his struggles at this time, Miller says, “Coffee and energy drinks were no longer helping me. Eventually, I was drinking so much caffeine that I was beginning to notice negative and troubling health effects.” He adds, “I believed there had to be a better way. Better technology that the earth was providing that I could implement and not only boost my daily performance but take care of my brain and body long-term.” After years of experiments and with the help of leading scientists, he developed Koios, named after the Greek Titan who represented rational intelligence.

Koios contains the following ingredients, among others:

  • Vitamin B12: Crucial for the function of the nervous system and the synthesis of DNA, B12 also helps in the creation of red blood cells.
  • Vitamin B6: This vitamin is crucial for brain development among children and brain function in adults. B6 is also important in the production of key hormones: serotonin, which regulates mood, norepinephrine, which helps us handle stress, and dopamine.
  • Huperzine A: Developed from the Chinese club moss plant, huperzine A is used on Alzheimer’s patients to boost their memories. It is also used to raise energy levels and alertness and is the subject of medical trials to test its efficacy when combined with other drugs.
  • Bacopa: Also known as brahmi, bacopa is an Indian herb used in Ayurvedic medicine to improve concentration and memory. Modern science has recognized its effectiveness, and it is used to treat symptoms caused by Alzheimer’s disease, ADHD and anxiety.
  • Ciwujia: Sports scientists have been interested in this herb since they heard of how mountain climbers in Tibet use it to boost their performance at high altitudes. Peer-reviewed research has shown that Ciwujia has clear positive effects on endurance.

A full breakdown of Koios’ active ingredients is available on the company website.

Additionally, safety is paramount for Koios, with all its products developed in a high-grade nutraceutical laboratory which is GMP-certified and in compliance with FDA guidelines. Koios only uses high-quality ingredients sourced from the best possible locations in order to deliver a product that is not only safe but also “one of the world’s greatest nootropic blends.”

The company’s products can be found online and in stores, both across the United States and internationally, via a continuously growing distribution network.

Koios CEO Chris Miller is supported by a team with strong credentials in medical supplement start-ups, corporate finance and sales, which includes CFO/Director Anthony Jackson, Director Scott Walters, Director Konstantine Lichtenwald and Vice President of Sales Gina Burrus.

With people seeking a mental edge and cognitive boost, Koios believes that there is an opening in the market for its nature-based, over-the-counter nootropics, especially when current prescription medicines have worrying side effects..

Koios Beverage Corp. (KBEVF), closed the day's trading session at $0.3941, off by 0.48%, on 484,230 volume with 228 trades. The average volume for the last 3 months is 375,036 and the stock's 52-week low/high is $0.001/$0.5121.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring SinglePoint, Inc. (OTCQB: SING), a client of NNW focused on acquiring companies that will benefit from the injection of growth capital and technology integration. To view the full publication, titled “Gambling and Tech Companies Charge into American Sports Betting Market,” visit: http://nnw.fm/RaN3D.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0261, off by 8.23%, on 6,797,180 volume with 256 trades. The average volume for the last 3 months is 3,715,992 and the stock's 52-week low/high is $0.02349/$0.133.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

Owing to recent surges in the price of its Canadian-listed shares, The Green Organic Dutchman’s (TSX: TGOD) (OTCQX: TGODF) market cap recently exceeded $2 billion. To view a detailed quote, visit: http://nnw.fm/Cui0U. Also today, the company was highlighted in an article analyzing how the Cannabidiol (CBD) infused products market continues to experience rapidly rising consumer demand as its multi-billion dollar revenues climb higher.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $5.528, off by 14.95%, on 2,857,153 volume with 6,620 trades. The average volume for the last 3 months is 402,048 and the stock's 52-week low/high is $2.784/$7.565.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.